Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2017 3
2018 4
2019 3
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). McDowell PJ, et al. Among authors: shrimanker r. Lancet Respir Med. 2021 Oct;9(10):1174-1184. doi: 10.1016/S2213-2600(21)00004-7. Epub 2021 May 7. Lancet Respir Med. 2021. PMID: 33971168
Emerging Biologics in Severe Asthma.
Pavord ID, Hilvering B, Shrimanker R. Pavord ID, et al. Among authors: shrimanker r. Immunol Allergy Clin North Am. 2016 Aug;36(3):609-23. doi: 10.1016/j.iac.2016.04.001. Immunol Allergy Clin North Am. 2016. PMID: 27401629 Review.
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.
Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP, Heaney LG, Fowler SJ, Bradding P, Pavord ID, Hinks TSC. Couillard S, et al. Among authors: shrimanker r. Am J Respir Crit Care Med. 2021 Sep 15;204(6):731-734. doi: 10.1164/rccm.202104-1040LE. Am J Respir Crit Care Med. 2021. PMID: 34129808 Free PMC article. No abstract available.
Non-invasive ventilation: initiation and initial management.
Addala D, Shrimanker R, Davies MG. Addala D, et al. Among authors: shrimanker r. Br J Hosp Med (Lond). 2017 Sep 2;78(9):C140-C144. doi: 10.12968/hmed.2017.78.9.C140. Br J Hosp Med (Lond). 2017. PMID: 28898158 Free article. No abstract available.
Exacerbations of severe asthma in patients treated with mepolizumab.
Shrimanker R, Pavord ID, Yancey S, Heaney LG, Green RH, Bradding P, Hargadon B, Brightling CE, Wardlaw AJ, Haldar P. Shrimanker R, et al. Eur Respir J. 2018 Dec 13;52(6):1801127. doi: 10.1183/13993003.01127-2018. Print 2018 Dec. Eur Respir J. 2018. PMID: 30464012 Free article. Clinical Trial. No abstract available.
Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.
Luo J, Wu Y, Shrimanker R, Go S, Ye Y, Hardman C, Nahler J, Chen YL, Stöger L, Zeng N, Liu W, Reed L, Tolkovsky AM, Klenerman P, Ogg G, Pavord ID, Xue L. Luo J, et al. Among authors: shrimanker r. J Allergy Clin Immunol. 2019 Dec;144(6):1722-1726.e10. doi: 10.1016/j.jaci.2019.08.008. Epub 2019 Aug 22. J Allergy Clin Immunol. 2019. PMID: 31445099 No abstract available.
16 results